ANI Pharmaceuticals ANIP
$68.55 −$0.58 (-0.84%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $68.55 0.00%
Open$68.96
Prev close$69.13
Day range$68.28 – $70.20
Volume227.3K
Market cap$1.56B
P/E (TTM)13.6
Dividend yield–
ANIP Stock News
Headlines matching ANI Pharmaceuticals or the ANIP ticker, most recent first.
- Leerink Partners Initiates ANI Pharmaceuticals(ANIP.US) With Buy Rating, Announces Target Price $104
- H.C. Wainwright Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $121
- Barclays Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $100
- J.P. Morgan Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $115
- Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Cuts Target Price to $119 Negative
- CCORF Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating, Cuts Target Price to $90 Negative
- CCORF Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating, Maintains Target Price $91
- CCORF Downgrades ANI Pharmaceuticals(ANIP.US) to Hold Rating, Raises Target Price to $91 Mixed
- Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $124
- Truist Financial Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating
- Piper Sandler Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $111 Positive
- Jefferies Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $120 Positive
- H.C. Wainwright Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $121
- CCORF Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating, Maintains Target Price $90
- Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $121 Positive
No comments yet — be the first to weigh in on ANIP.
Sign in to join the discussion.